-
EP3283513
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3283513
| EP3283513 - ANTIBODY DIRECTED AGAINST IMMUNOGLOBULIN-BINDING PROTEINS OF S. AUREUS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.10.2020 Database last updated on 08.04.2026 | |
| Former | Examination is in progress Status updated on 04.02.2019 | ||
| Former | Request for examination was made Status updated on 19.01.2018 | ||
| Former | The international publication has been made Status updated on 04.04.2017 | Most recent event Tooltip | 09.10.2020 | Application deemed to be withdrawn | published on 11.11.2020 [2020/46] | Applicant(s) | For all designated states ARSANIS Biosciences GmbH Helmut-Qualtinger-Gasse 2 1030 Vienna / AT | [2018/08] | Inventor(s) | 01 /
NAGY, Eszter Westbahnstrasse 32-34/I/12 1070 Vienna / AT | 02 /
BADARAU, Adriana Steingasse 19/7 1030 Vienna / AT | 03 /
ROUHA, Harald Schüttaustrasse 48/ Top 14 1220 Wien / AT | 04 /
STULIK, Lukas Sandleitengasse 17/1/5 1160 Vienna / AT | 05 /
MIRKINA, Irina Harkortstrasse 7/Top 4 1020 Vienna / AT | 06 /
BATTLES, Michael B. 7 Lucent Drive Lebanon, New Hampshire 03766 / US | 07 /
NIELSON, Nels 7 Lucent Drive Lebanon, New Hampshire 03766 / US | [2018/08] | Representative(s) | Redl, Gerda, et al Redl Life Science Patents OG Donau-City-Straße 11 1220 Wien / AT | [N/P] |
| Former [2018/08] | Redl, Gerda, et al REDL Life Science Patent Attorneys Donau-City-Straße 11 1220 Wien / AT | Application number, filing date | 16716236.1 | 14.04.2016 | [2018/08] | WO2016EP58238 | Priority number, date | EP20150163996 | 17.04.2015 Original published format: EP 15163996 | [2018/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016166221 | Date: | 20.10.2016 | Language: | EN | [2016/42] | Type: | A1 Application with search report | No.: | EP3283513 | Date: | 21.02.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.10.2016 takes the place of the publication of the European patent application. | [2018/08] | Search report(s) | International search report - published on: | EP | 20.10.2016 | Classification | IPC: | C07K16/12, C07K16/42 | [2018/08] | CPC: |
C07K16/1271 (EP,CN,KR,US);
A61K39/40 (US);
A61P11/00 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P31/04 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
G01N33/56938 (CN,KR);
A61K2039/505 (KR,US);
C07K2317/21 (EP,CN,KR,US);
C07K2317/24 (US);
C07K2317/33 (EP,CN,KR,US);
C07K2317/34 (EP,CN,KR,US);
C07K2317/55 (US);
C07K2317/565 (US);
C07K2317/76 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/08] | Title | German: | GEGEN IMMUNOGLOBULINBINDENDE PROTEINE VON S. AUREUS GERICHTETER ANTIKÖRPER | [2018/08] | English: | ANTIBODY DIRECTED AGAINST IMMUNOGLOBULIN-BINDING PROTEINS OF S. AUREUS | [2018/08] | French: | ANTICORPS DIRIGÉS CONTRE LES PROTÉINES DE LIAISON À L'IMMUNOGLOBULINE DE S. AUREUS | [2018/08] | Entry into regional phase | 06.11.2017 | National basic fee paid | 06.11.2017 | Designation fee(s) paid | 06.11.2017 | Examination fee paid | Examination procedure | 17.02.2017 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.11.2017 | Amendment by applicant (claims and/or description) | 06.11.2017 | Examination requested [2018/08] | 06.11.2017 | Date on which the examining division has become responsible | 07.02.2019 | Despatch of a communication from the examining division (Time limit: M06) | 23.07.2019 | Reply to a communication from the examining division | 16.12.2019 | Despatch of a communication from the examining division (Time limit: M04) | 03.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/46] | 25.06.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/46] | Fees paid | Renewal fee | 23.04.2018 | Renewal fee patent year 03 | 27.09.2019 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.04.2019 | 04 M06 Fee paid on 27.09.2019 | 30.04.2020 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XD] US2014170134 (SCHNEEWIND OLAF et al.) [XD] 1-18 * the whole document * | [X] WO2013096948 (LYDON NICHOLAS B et al.) [X] 1-18 * the whole document * | [X] WO0140306 (BIOSITE DIAGNOSTICS INC et al.) [X] 1-18 * example 22 * | [X] WO2014114801 (AMGEN INC et al.) [X] 1-18 * the whole document * | [X] WO2006031653 (WYETH CORP et al.) [X] 1-18 * example 5; sequences 66, 20 * | [X] H. K. KIM ET AL: "Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus aureus Disease in Mice", INFECTION AND IMMUNITY, vol. 80, no. 10, 23 July 2012 (2012-07-23), pages 3460 - 3470, XP055204432, ISSN: 0019-9567, DOI: 10.1128/IAI.00230-12 [X] 1-18 * column r - page 3464, paragraph 4 * * page 3465 - column l * DOI: http://dx.doi.org/10.1128/IAI.00230-12 |